Authors: Kohda, K Sakamaki, S Matsunaga, T Kuga, T Fujimi, A Konuma, Y Kusakabe, T Kogawa, K Akiyama, T Koike, K Hirayama, Y Sasagawa, Y Nojiri, S Hirata, Y Nishisato, T Niitsu, Y

Citation: K. Kohda et al., Long-term survival and late-onset complications of cancer patients treatedwith high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation, INT J HEMAT, 73(2), 2001, pp. 251-257

Authors: Lu, Y Sakamaki, S Kuroda, H Kusakabe, T Konuma, Y Akiyama, T Fujimi, A Takemoto, N Nishiie, K Matsunaga, T Hirayama, Y Kato, J Kon, S Kogawa, K Niitsu, Y

Citation: Y. Lu et al., Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603, BLOOD, 97(4), 2001, pp. 1123-1130

Authors: Matsunaga, T Sakamaki, S Kuga, T Kuroda, H Kusakabe, T Akiyama, T Konuma, Y Hirayama, Y Kobune, M Kato, J Sasaki, K Kogawa, K Koyama, R Niitsu, Y

Citation: T. Matsunaga et al., GST-pi gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity cyclophosphamide in mice, HUM GENE TH, 11(12), 2000, pp. 1671-1681

Authors: Sakamaki, S Hirayama, Y Matsunaga, T Kuroda, H Kusakabe, T Akiyama, T Konuma, Y Sasaki, K Tsuji, N Okamoto, T Kobune, M Kogawa, K Kato, J Takimoto, R Koyama, R Niitsu, Y

Citation: S. Sakamaki et al., Transforming growth factor-beta 1 (TGF-beta 1) induces thrombopoietin frombone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity, BLOOD, 94(6), 1999, pp. 1961-1970